TY - JOUR
T1 - Correlation between the duration of locoregional control and survival in T1–T2 oropharyngeal cancer patients
AU - Caula, Alexandre
AU - Boukhris, Marc
AU - Guerlain, Joanne
AU - Tao, Yungan
AU - Breuskin, Ingrid
AU - Mirghani, Haitham
AU - Temam, Stéphane
AU - Gorphe, Philippe
N1 - Publisher Copyright:
© 2019, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Purpose: To investigate the correlation between the time to locoregional recurrence and survival in T1–T2 oropharyngeal squamous-cell carcinoma (OPSCC) patients. Methods: A retrospective, single-site study of patients with T1–T2 OPSCC treated with curative intent between 2000 and 2015 who had a locoregional recurrence without distant metastases. Patients without a disease-free interval (i.e., persistent macroscopic disease after the end of treatment and a time to locoregional recurrence of less than 3 months) were excluded. The endpoint considered was overall survival (OS). Results: Out of 602 T1–T2 OPSCC patients, 121 patients had a locoregional recurrence and they were, hence, analyzed. All of the patients were heavy-smokers, with a consumption of more than 20 pack-years. The recurrence was local in 59.5%, regional in 27.3%, and both local and regional in 13.2% of the patients. The median time to locoregional recurrence and median OS was 15 months and 44 months, respectively. The time to locoregional recurrence was correlated with OS (p < 0.0001). In multivariate analyses, factors associated with survival were an initial N0–N2a versus N2b–N3 nodal staging and a 12-month threshold for the time to locoregional recurrence. Conclusions: Locoregional control in T1–T2 OPSCC is not only a qualitative prognostic factor but also a quantitative prognostic factor of survival. A time to locoregional recurrence of less than 12 months was correlated with an unfavorable prognosis.
AB - Purpose: To investigate the correlation between the time to locoregional recurrence and survival in T1–T2 oropharyngeal squamous-cell carcinoma (OPSCC) patients. Methods: A retrospective, single-site study of patients with T1–T2 OPSCC treated with curative intent between 2000 and 2015 who had a locoregional recurrence without distant metastases. Patients without a disease-free interval (i.e., persistent macroscopic disease after the end of treatment and a time to locoregional recurrence of less than 3 months) were excluded. The endpoint considered was overall survival (OS). Results: Out of 602 T1–T2 OPSCC patients, 121 patients had a locoregional recurrence and they were, hence, analyzed. All of the patients were heavy-smokers, with a consumption of more than 20 pack-years. The recurrence was local in 59.5%, regional in 27.3%, and both local and regional in 13.2% of the patients. The median time to locoregional recurrence and median OS was 15 months and 44 months, respectively. The time to locoregional recurrence was correlated with OS (p < 0.0001). In multivariate analyses, factors associated with survival were an initial N0–N2a versus N2b–N3 nodal staging and a 12-month threshold for the time to locoregional recurrence. Conclusions: Locoregional control in T1–T2 OPSCC is not only a qualitative prognostic factor but also a quantitative prognostic factor of survival. A time to locoregional recurrence of less than 12 months was correlated with an unfavorable prognosis.
KW - Disease-free interval
KW - Locoregional recurrence
KW - Oropharyngeal neoplasms
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=85060480387&partnerID=8YFLogxK
U2 - 10.1007/s00405-019-05293-z
DO - 10.1007/s00405-019-05293-z
M3 - Article
C2 - 30666440
AN - SCOPUS:85060480387
SN - 0937-4477
VL - 276
SP - 1161
EP - 1166
JO - European Archives of Oto-Rhino-Laryngology
JF - European Archives of Oto-Rhino-Laryngology
IS - 4
ER -